Customer Publication

FGF23 promotes proliferation, migration and invasion by regulating miR-340-5p in osteosarcoma

Authors: Fang, Lun et al.

Journal: Journal of Orthopaedic Surgery and Research (2023)

Institution: Institute of Sports Medicine, Shandong First Medical University and Shandong Academy Medical Sciences, Taian, People’s Republic of China

Research Areas: Cancer research

Cell Lines: hFOB1.19, OS, MG-63, U2-OS (Osteoblast cell line)

Summary: Osteosarcoma is a primary malignant bone tumor with high metastasis and high recurrence. There is increased evidence suggesting that FGF 23 is associated with the biological behavior of malignant tumors. This study indicated FGF 23 is highly expressed in osteosarcoma cells. Overexpression of FGF23 can promote the proliferation, migration and invasion of osteosarcoma cells by targeting miR-340-5p gene expression. The results of this study suggest that FGF23 may be an effective molecular target for the clinical treatment of osteosarcoma. HoloMonitor was used to track the trajectory of single-cell motility. The migration distance of cells in the ad-FGF23 group was significantly increased compared with the control group.

Keywords: HoloMonitor, singel cell tracking, orthopedics, surgical orthopedics

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.com

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.com

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2